Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Harvard Business School
Fish and Richardson
US Department of Justice
Merck
Argus Health
Moodys
Cerilliant
Colorcon

Generated: May 25, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 040475

« Back to Dashboard

NDA 040475 describes DIHYDROERGOTAMINE MESYLATE, which is a drug marketed by Hikma Pharms, Paddock Llc, and West-ward Pharms Int, and is included in three NDAs. It is available from two suppliers. Additional details are available on the DIHYDROERGOTAMINE MESYLATE profile page.

The generic ingredient in DIHYDROERGOTAMINE MESYLATE is dihydroergotamine mesylate. There are five drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the dihydroergotamine mesylate profile page.
Summary for 040475
Tradename:DIHYDROERGOTAMINE MESYLATE
Applicant:Paddock Llc
Ingredient:dihydroergotamine mesylate
Patents:0
Therapeutic Class:Antimigraine Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 040475
Ingredient-typeErgotamines
Medical Subject Heading (MeSH) Categories for 040475
Suppliers and Packaging for NDA: 040475
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
DIHYDROERGOTAMINE MESYLATE dihydroergotamine mesylate INJECTABLE;INJECTION 040475 ANDA Paddock Laboratories, LLC 0574-0850 N 0574-0850-05
DIHYDROERGOTAMINE MESYLATE dihydroergotamine mesylate INJECTABLE;INJECTION 040475 ANDA Paddock Laboratories, LLC 0574-0850 N 0574-0850-10

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength1MG/ML
Approval Date:Apr 28, 2003TE:APRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Argus Health
Cerilliant
Julphar
US Army
Colorcon
Express Scripts
Federal Trade Commission
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.